Annexin A2 promotion of hepatocellular carcinoma tumorigenesis via the immune microenvironment
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Annexin A2 promotion of hepatocellular carcinoma tumorigenesis via the immune microenvironment
Authors
Keywords
-
Journal
WORLD JOURNAL OF GASTROENTEROLOGY
Volume 26, Issue 18, Pages 2126-2137
Publisher
Baishideng Publishing Group Inc.
Online
2020-05-14
DOI
10.3748/wjg.v26.i18.2126
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Systemic Treatment for Advanced Hepatocellular Carcinoma
- (2019) Mohamed Bouattour et al. Liver Cancer
- Atezolizumab plus bevacizumab and chemotherapy in non-small-cell lung cancer (IMpower150): key subgroup analyses of patients with EGFR mutations or baseline liver metastases in a randomised, open-label phase 3 trial
- (2019) Martin Reck et al. Lancet Respiratory Medicine
- Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma
- (2019) Ying Jiang et al. NATURE
- The miR155HG/miR-185/ANXA2 loop contributes to glioblastoma growth and progression
- (2019) Weining Wu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Cell-surface Translocation of Annexin A2 contributes to bleomycin-induced pulmonary fibrosis by mediating inflammatory response in mice
- (2019) Yunlong Lei et al. CLINICAL SCIENCE
- Annexin A2 and S100A10 as Candidate Prognostic Markers in Epithelial Ovarian Cancer
- (2019) MARIA V. CHRISTENSEN et al. ANTICANCER RESEARCH
- A Psoriasiform Drug Eruption Secondary to Nivolumab for Hepatocellular Carcinoma: A Case Report
- (2019) Matthew J. Stotts et al. HEPATOLOGY
- ANXA2Tyr23 and FLNASer2152 phosphorylation associate with poor prognosis in hepatic carcinoma revealed by quantitative phosphoproteomics analysis
- (2019) Xiaohua Xing et al. Journal of Proteomics
- Annexin A2 interacting with ELMO1 regulates HCC chemotaxis and metastasis
- (2019) Hongyan Li et al. LIFE SCIENCES
- Annexin�A2 regulates glioma cell proliferation through the STAT3‑cyclin�D1 pathway
- (2019) Ling Chen et al. ONCOLOGY REPORTS
- Anti-pancreatic tumor efficacy of a Listeria-based, Annexin A2-targeting immunotherapy in combination with anti-PD-1 antibodies
- (2019) Victoria M. Kim et al. Journal for ImmunoTherapy of Cancer
- ANXA2 Silencing Inhibits Proliferation, Invasion, and Migration in Gastric Cancer Cells
- (2019) Rui Xie et al. Journal of Oncology
- Interaction of HE4 and ANXA2 exists in various malignant cells—HE4–ANXA2–MMP2 protein complex promotes cell migration
- (2019) Jing Wang et al. Cancer Cell International
- A combined ANXA2-NDRG1-STAT1 gene signature predicts response to chemoradiotherapy in cervical cancer
- (2019) Marianna Buttarelli et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Nivolumab in advanced hepatocellular carcinoma: Sorafenib-experienced Asian cohort analysis
- (2019) Thomas Yau et al. JOURNAL OF HEPATOLOGY
- Annexin A2 Enhances the Progression of Colorectal Cancer and Hepatocarcinoma via Cytoskeleton Structural Rearrangements
- (2019) Huimin He et al. MICROSCOPY AND MICROANALYSIS
- Checkpoint inhibitor-induced liver injury: A novel form of liver disease emerging in the era of cancer immunotherapy
- (2019) Yoh Zen et al. SEMINARS IN DIAGNOSTIC PATHOLOGY
- β-Catenin Activation Promotes Immune Escape and Resistance to Anti–PD-1 Therapy in Hepatocellular Carcinoma
- (2019) Marina Ruiz de Galarreta et al. Cancer Discovery
- HCC-Derived Exosomes: Critical Player and Target for Cancer Immune Escape
- (2019) Qiuju Han et al. Cells
- Statin Use and the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B
- (2019) Myung Ji Goh et al. HEPATOLOGY
- LncRNA SNHG14 potentiates pancreatic cancer progression via modulation of annexin A2 expression by acting as a competing endogenous RNA for miR‐613
- (2019) Peng‐cheng Deng et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- High levels of ANXA2 are characteristic of malignant salivary gland tumors
- (2019) Claudio Marcelo Cardoso et al. JOURNAL OF ORAL PATHOLOGY & MEDICINE
- High expression of Annexin A2 is associated with DNA repair, metabolic alteration, and worse survival in pancreatic ductal adenocarcinoma
- (2019) Hideo Takahashi et al. SURGERY
- The Relative Risk of Immune-Related Liver Dysfunction of PD-1/PD-L1 Inhibitors Versus Chemotherapy in Solid Tumors: A Meta-Analysis of Randomized Controlled Trials
- (2019) Siyao Deng et al. Frontiers in Pharmacology
- Identification of Prognostic Candidate Genes in Breast Cancer by Integrated Bioinformatic Analysis
- (2019) Wang et al. Journal of Clinical Medicine
- Review article: new therapeutic interventions for advanced hepatocellular carcinoma
- (2019) Saroja Bangaru et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- High Co-expression of Large Tenascin C Splice Variants in Stromal Tissue and Annexin A2 in Cancer Cell Membranes is Associated with Poor Prognosis in Pancreatic Cancer
- (2019) Kei Hagiwara et al. ANNALS OF SURGICAL ONCOLOGY
- Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma
- (2019) Qiang Gao et al. CELL
- Molecular targeted and immune checkpoint therapy for advanced hepatocellular carcinoma
- (2019) Ziyu Liu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Neuroserpin regulates human T cell‐T cell interactions and proliferation through inhibition of tissue plasminogen activator
- (2019) Evert Jan Loef et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Evaluating the Safety and Efficacy of Nivolumab in Patients with Advanced Hepatocellular Carcinoma: Evidence to Date
- (2019) Sri Harsha Tella et al. OncoTargets and Therapy
- Expression levels and prognostic values of annexins in liver cancer
- (2019) Chunbo Zhuang et al. Oncology Letters
- Multi-omics Analysis of Microenvironment Characteristics and Immune Escape Mechanisms of Hepatocellular Carcinoma
- (2019) Wenli Li et al. Frontiers in Oncology
- Tackling hepatocellular carcinoma with individual or combinatorial immunotherapy approaches
- (2019) Maria Tagliamonte et al. CANCER LETTERS
- Meta-analysis of the efficacy and safety of PD-1/PD-L1 inhibitors administered alone or in combination with anti-VEGF agents in advanced hepatocellular carcinoma
- (2019) Zhichao Feng et al. GUT
- Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial
- (2019) Richard S. Finn et al. JOURNAL OF CLINICAL ONCOLOGY
- Chemotherapy combined with bevacizumab for the treatment of advanced lung adenocarcinoma cancer harboring EGFR‐ANXA2, EGFR‐RAD51, ATR and BRCA2 mutations: A case report
- (2019) Rui Zhong et al. Thoracic Cancer
- Long noncoding RNA cytoskeleton regulator RNA promotes cell invasion and metastasis by titrating miR‐613 to regulate ANXA2 in nasopharyngeal carcinoma
- (2019) Wei Chen et al. Cancer Medicine
- Extracellular Vesicles-Based Biomarkers Represent a Promising Liquid Biopsy in Endometrial Cancer
- (2019) Carolina Herrero et al. Cancers
- Identification of ANXA2 (annexin A2) as a specific bleomycin target to induce pulmonary fibrosis by impeding TFEB-mediated autophagic flux
- (2018) Kui Wang et al. Autophagy
- Cancer-associated fibroblasts promote epithelial-mesenchymal transition and EGFR-TKI resistance of non-small cell lung cancers via HGF/IGF-1/ANXA2 signaling
- (2018) Yanmei Yi et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- HCC risk in patients with HBV-related cirrhosis receiving nucleos(t)ide analogues therapy: Is HCC prevented or delayed?
- (2018) Tung-Hung Su et al. HEPATOLOGY
- Pembrolizumab for metastatic hepatocellular carcinoma following live donor liver transplantation: The silver bullet?
- (2018) Ashwin Rammohan et al. HEPATOLOGY
- The immunology of hepatocellular carcinoma
- (2018) Marc Ringelhan et al. NATURE IMMUNOLOGY
- Ginsenoside compound K inhibits nuclear factor-kappa B by targeting Annexin A2
- (2018) Yu-Shi Wang et al. Journal of Ginseng Research
- Identification of natural compounds targeting Annexin A2 with an anti-cancer effect
- (2018) Yu-Shi Wang et al. Protein & Cell
- TRIM65 supports bladder urothelial carcinoma cell aggressiveness by promoting ANXA2 ubiquitination and degradation
- (2018) Wen-Su Wei et al. CANCER LETTERS
- Annexin A2 (ANX A2): An Emerging Biomarker and Potential Therapeutic Target for Aggressive Cancers
- (2018) Mahesh C. Sharma INTERNATIONAL JOURNAL OF CANCER
- ANXA2 promotes esophageal cancer progression by activating MYC-HIF1A-VEGF axis
- (2018) Sai Ma et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Molecular therapies and precision medicine for hepatocellular carcinoma
- (2018) Josep M. Llovet et al. Nature Reviews Clinical Oncology
- The hepatocellular carcinoma market
- (2018) Joshua Dawkins et al. NATURE REVIEWS DRUG DISCOVERY
- Annexin A2 overexpression associates with colorectal cancer invasiveness and TGF-ß induced epithelial mesenchymal transition via Src/ANXA2/STAT3
- (2018) Murilo R. Rocha et al. Scientific Reports
- Heterotetrameric annexin A2/S100A10 (A2t) is essential for oncogenic human papillomavirus trafficking and capsid disassembly, and protects virions from lysosomal degradation
- (2018) Julia R. Taylor et al. Scientific Reports
- ANXA2 expression in African American triple-negative breast cancer patients
- (2018) Lee D. Gibbs et al. BREAST CANCER RESEARCH AND TREATMENT
- Long non-coding RNA LUCAT1 promotes tumourigenesis by inhibiting ANXA2 phosphorylation in hepatocellular carcinoma
- (2018) Yun Lou et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Reciprocal regulation of pro-inflammatory Annexin A2 and anti-inflammatory Annexin A1 in the pathogenesis of rheumatoid arthritis
- (2018) Vikram Haridas et al. MOLECULAR BIOLOGY REPORTS
- Cancer-related gene expression is associated with disease severity and modifiable lifestyle-factors in non-alcoholic fatty liver disease
- (2018) Bianca M. Arendt et al. NUTRITION
- Annexin A2 in Virus Infection
- (2018) Julia R. Taylor et al. Frontiers in Microbiology
- Annexin A2 contributes to cisplatin resistance by activation of JNK-p53 pathway in non-small cell lung cancer cells
- (2017) Xiaomin Feng et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Annexin A2 could enhance multidrug resistance by regulating NF-κB signaling pathway in pediatric neuroblastoma
- (2017) Yi Wang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Immunotherapy: Nivolumab keeps HCC in check and opens avenues for checkmate
- (2017) David Killock Nature Reviews Clinical Oncology
- Annexin A2 inhibition suppresses ovarian cancer progression via regulating β-catenin/EMT
- (2017) Yan Liu et al. ONCOLOGY REPORTS
- Mycoplasma-associated multidrug resistance of hepatocarcinoma cells requires the interaction of P37 and Annexin A2
- (2017) Danyang Liu et al. PLoS One
- Sensing of cell stress by human γδ TCR-dependent recognition of annexin A2
- (2017) Romain Marlin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Expression of annexin II in gastric carcinoma and its role in gastric cancer metastasis
- (2017) Feng Han et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Annexin A2 is an independent prognostic biomarker for evaluating the malignant progression of laryngeal cancer
- (2017) Shi Luo et al. Experimental and Therapeutic Medicine
- Stromal Annexin A2 expression is predictive of decreased survival in pancreatic cancer
- (2017) Adrian G. Murphy et al. Oncotarget
- Prognostic impact of AnxA1 and AnxA2 gene expression in triple-negative breast cancer
- (2017) Lee D. Gibbs et al. Oncotarget
- Annexin A2-S100A10 heterotetramer is upregulated by PML/RARα fusion protein and promotes plasminogen-dependent fibrinolysis and matrix invasion in acute promyelocytic leukemia
- (2017) Dan Huang et al. Frontiers of Medicine
- Challenges of advanced hepatocellular carcinoma
- (2016) Stefano Colagrande et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Robust enumeration of cell subsets from tissue expression profiles
- (2015) Aaron M Newman et al. NATURE METHODS
- Up-regulation of annexin A2 expression predicates advanced clinicopathological features and poor prognosis in hepatocellular carcinoma
- (2015) Haijian Zhang et al. TUMOR BIOLOGY
- Dendritic cells respond to nasopharygeal carcinoma cells through annexin A2-recognizing DC-SIGN
- (2015) Pin-Zhir Chao et al. Oncotarget
- Annexin A2 System in Human Biology: Cell Surface and Beyond
- (2013) Min Luo et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Annexin A2 silencing inhibits invasion, migration, and tumorigenic potential of hepatoma cells
- (2013) Hai-Jian Zhang WORLD JOURNAL OF GASTROENTEROLOGY
- Expression characteristics and diagnostic value of annexin A2 in hepatocellular carcinoma
- (2012) Hai-Jian Zhang WORLD JOURNAL OF GASTROENTEROLOGY
- S100A10 regulates plasminogen-dependent macrophage invasion
- (2010) P. A. O'Connell et al. BLOOD
- Up regulation of annexin A2 on murine H22 hepatocarcinoma cells induced by cartilage polysaccharide
- (2010) Anjun Liu et al. Cancer Epidemiology
- Subcellular proteome analysis unraveled annexin A2 related to immune liver fibrosis
- (2010) Lijun Zhang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Exosomes: Extracellular organelles important in intercellular communication
- (2010) Suresh Mathivanan et al. Journal of Proteomics
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started